Elexacaftor –tezacaftor–ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosis

ConclusionsTreatment with ETI leads to a reduction inPseudomonas abundance within the sinonasal microbiome of individuals withPseudomonas at baseline.

Source: International Forum of Allergy and Rhinology - October 15, 2023 Category: Allergy & Immunology Authors: Anna C. Zemke, Yasmin Hilliam, Amanda L. Stapleton, Adam J. Kimple, Jennifer L. Goralski, Amber D. Shaffer, Joseph M. Pilewski, Brent A. Senior, Stella E. Lee, Vaughn S. Cooper Tags: ORIGINAL ARTICLE Source Type: research